Sai Life Sciences Ltd reports Q2 FY27 revenue of ₹659 crore, up 23% year-on-year
- EBITDA rose 20% to ₹187 crore; margin was 28%, versus 29% a year earlier.
- Net profit increased 17% to ₹98 crore.
- H1 FY27 capex was ₹621 crore; results are unaudited.
Sai Life Sciences Q2 FY27 Earnings Release
This is an automated summary of a public document. Always check the original before relying on it.